Search
Search Results
##search.searchResults.foundPlural##
-
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3569PDF: 1357HTML: 2395Fi.1 Gritti.Rambaldi: 255 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1524PDF: 878HTML: 3145 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3949PDF: 1752HTML: 11917Figures Haase: 259 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3896PDF: 1676HTML: 874Figures . Eliassian: 278 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2360PDF: 933HTML: 2021Fig 1 Rossi: 241 -
Severe eosinophilia in a case of giardiasis
1143PDF: 1629HTML: 460 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2881PDF: 1028HTML: 4735 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1803PDF: 658HTML: 300 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4177PDF: 1608HTML: 9315Untitled: 322Untitled: 226Untitled: 207Untitled: 208Untitled: 223Untitled: 374 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3757PDF: 2623HTML: 1663 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
3176PDF: 935HTML: 6619Untitled: 278Untitled: 238Untitled: 254Untitled: 262 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
5095PDF: 2965HTML: 2360 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1290PDF: 793Html: 122 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1551PDF: 1396HTML: 120 -
-
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3341PDF: 1417HTML: 4160 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5888PDF: 1598HTML: 1668Untitled: 277 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
3035PDF: 1079HTML: 5661 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1392PDF: 1175PDF: 931HTML: 255 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1656PDF: 1175HTML: 272 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3445PDF: 1021HTML: 3013 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277853PDF: 1875HTML: 3907 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1295PDF: 641HTML: 6935







